Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : ACMI - Accumed Inc. -- Ignore unavailable to you. Want to Upgrade?

To: Frank Buck who wrote (595)	12/3/1997 1:35:00 AM
From: Ryan Weisman	Read Replies (1) \| Respond to of 1894

Wow! You should write ACMI's commercial jingles. BTW, I saw we got press the other day. I turned to the Cartoon Channel, and when Wild E. Coyote tried to trick the Road Runner with ACMI's latest product, boy was he surprised when it backfired. Stock should move tomorrow! Did Cisco really sell? Whoa, that's too bad. Ciiiiiii-scooooo. WHerever you are, hope you jump back on board with any further weakness. This baby is going to rise faster than it dropped, and 2 months until the quarterly report doesn't seem long to wait at this point.

To: Frank Buck who wrote (595)	12/3/1997 4:59:00 AM
From: Cisco	Read Replies (1) \| Respond to of 1894

Frank, I'm really touched! Have you been practicing your positive thinking?<g> psicop.com I've been waiting to see who AccuMed's new PR firm is? Judging from Ryan's last post about Wild E. Coyote I thought maybe it was this firm, but I didn't see ACMI on the Psychic Stock Pick List: psicop.com Sure would be nice to know what is going on at AccuMed! To you think we could get one of their people to post to this thread? Sorry, just dreaming. Cisco

To: Frank Buck who wrote (595)	12/3/1997 10:28:00 AM
From: Frank Buck	Respond to of 1894

To all ACMI holders. Here is an editted cut and paste of an Email I received from another AccuMed stockholder. He is an avid reader of this thread and was gracious enough to share with us his recent Q & A period with the " top-powers that be" at AccuMed H.Q.'s Q: Are the cytopathology units selling and if so, why haven't we seen any announcements? A: YES, the lack of announcements comes from the fact that the labs have been prohibiting the use of any public statements without a thorough trial time period. Q: When will be see some announcements/results of your work? A: Before the end of the year (clarified as Dec 31, 1997), and we will see multiple announcements. Q: What are the forecasts for break even? A: The target is still the middle of 1998 and he feels confident that that can occur. Along with talking with Peter this morning I spoke with Sandesh Seth, the analysist at Commonwealth Associates who follows ACMI. Based on the steady cash flow from the microbiology division, the stock should not be sold at these prices and looks VERY attractive. My personal opinion is that they need to change the mission statement of the company to reflect a "complete laboratory diagnostic" company. Too much emphasis is being placed on a small part of the revenue stream. --End-- Thanks very, very much "mystery man" for sharing this inforamtion with us. I am sure all the ACMI thread readers will be gratified that the rescue-helicopter is on the way. Guys some nice thank-yous' are in order, don't you think! By the way the Company's mission statement is: The Company's mission is to develop and market cost effective, reliable and innovative diagnostic products for the laboratory segment of the health care industry. The Company's strategy is, and will continue to be, relavant and driven by the current developments, and pressures in the health care industry. Particularly, the Company's focus includes: (1) Early detection testing products which reduce overall health care costs, (2) Faster and more accurate tests which also reduce costs and turnaround time, (3) Broadbased segmented product strategies that allow for market expansion and incremental system integration by the customer, (4) Cost effective modular product design strategies, (5) Automated evaluation products which reduce administration expense, (6) Data transmission features to meet the growing trend in networking, diverse communication methods, and facility consolidations, (7) International research and marketing to meet the growing international markets, and (8) The use of strategic relationships where possible to be the low cost supplier. Bdab, bdab, bdab...that's allll folks ! Frank